Insiders · ANGO

Scott Centea

Officer at Angiodynamics Inc (ANGO)

Scott Centea has filed 11 insider reports with the SEC since July 2021, as officer at Angiodynamics Inc (ANGO). Scott Centea made no open-market purchases or sales in the last 12 months. The latest filing, on September 22, 2023, reports shares withheld for taxes or exercise price and exercise or conversion of a derivative at Angiodynamics Inc (ANGO).

Filings
11
Companies
1
Bought on market
None
Sold on market
$335K

Companies where Scott Centea is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Angiodynamics Inc logo
ANGO
Angiodynamics Inc
Officer62,951$335K$10.76Sep 22, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Scott Centea with

Other insiders at the same companies

Questions about Scott Centea

What is Scott Centea's role at Angiodynamics Inc?
Scott Centea reports to the SEC as officer at Angiodynamics Inc (ANGO), according to the latest filing on September 22, 2023.
How many shares does Scott Centea own?
After the latest filing that states it, Scott Centea directly owned 62,951 shares of Angiodynamics Inc (ANGO). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Scott Centea bought or sold stock recently?
The most recent open-market sale was on October 15, 2021: sold 12,000 shares of Angiodynamics Inc (ANGO) for $335K at an average of $27.92.
How do I get alerts when Scott Centea files?
Follow Scott Centea on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Scott Centea (SEC CIK 0001823973). Totals count each trade once, skipping amendments whose original is on file, from Jul 23, 2021 on. View on SEC EDGAR · Get this as JSON